Genelon Institute Of Life Science Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 5.60 M
- Company Age 13 Year, 12 Days
- Last Filing with ROC 31 Mar 2022
- Revenue Growth %
- Net Worth -130.61%
- Total Assets -60.44%
About Genelon Institute Of Life Science
Genelon Institute Of Life Science Private Limited (GIOLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 February 2012 and has a history of 13 years. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Biotechnology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 5.60 M, as per Ministry of Corporate Affairs (MCA) records.
Subbarao Bharathi and Muniyappa Muniraj serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U15100KA2012PTC062530
- Company No.
062530
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Feb 2012
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Genelon Institute Of Life Science?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subbarao Bharathi  | Director | 14-Feb-2012 | Current |
| Muniyappa Muniraj | Director | 14-Feb-2012 | Current |
Financial Performance of Genelon Institute Of Life Science.
Genelon Institute Of Life Science Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 130.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Genelon Institute Of Life Science?
In 2018, Genelon Institute Of Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ci Concrete India Private LimitedSubbarao Bharathi and Muniyappa Muniraj are mutual person
Vagus Super Speciality Hospital Private LimitedMuniyappa Muniraj is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Genelon Institute Of Life Science?
Unlock and access historical data on people associated with Genelon Institute Of Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genelon Institute Of Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genelon Institute Of Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
